🇺🇸 FDA

Company profile · Sponsor

Pharma

Pharma Mar S.A.

E2629AD · EMA pharma Colmenar Viejo, ES
Pipeline
24
Drugs
0
Patents
0

Quick answer

Pharma (E2629AD) is a pharma company. headquartered in Colmenar Viejo, ES. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E2629AD
Exchange EMA
Company type pharma
Headquarters Colmenar Viejo, ES

Pipeline (24)

Search pipeline →

  1. -, PARACETAMOL , CILAZAPRIL , Dapirolizumab pegol, EPINEPHRINE , DIPHENHYDRAMINE , -, -, -, -, -, -, -

    Pharma

    Systemic lupus erythematosus (SLE)

    phase 3 small molecule active

    1 trial

  2. -, Rozanolixizumab

    Pharma

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  3. -, Rozanolixizumab

    Pharma

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  4. A 52-Week, Open-Label Extension Study of ACP-204 in Adults with Alzheimer's Disease Psychosis

    Pharma

    Alzheimer's Disease Psychosis

    phase 3 other active

    1 trial

  5. A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

    Pharma

    Lewy body Dementia psychosis (LBDP)

    phase 3 other active

    1 trial

  6. ABIRATERONE, 177Lu-PNT2002, GALLIUM (68GA) GOZETOTIDE , ENZALUTAMIDE

    Pharma

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 3 small molecule active

    1 trial

  7. ABO-102, ABO-102, ABO-102

    Pharma

    Mucopolysaccharidosis type IIIA

    phase 3 small molecule active

    1 trial

  8. AMX0035, PL1 Oral powder in sachet, oral use

    Pharma

    Amyotrophic Lateral Sclerosis (ALS)

    phase 3 small molecule active

    1 trial

  9. APL-2

    Pharma

    Geographic Atrophy Secondary to Age-Related Macular Degeneration

    phase 3 small molecule active

    1 trial

  10. ATENATIV 50 UI/mL, poudre et solvant pour solution pour perfusion, Atenativ 1000 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Atenativ 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Infusionslösung, Atenativ 1000 UI/20 ml polvere e solvente per soluzione per infusione endovenosa, Atenativ 50 NE/ml por és oldószer oldatos infúzióhoz vagy injekcióhoz, ATENATIV 1000 U.I., polvo y disolvente para solución para perfusión

    Pharma

    Congenital antithrombin deficiency

    phase 3 small molecule active

    1 trial

  11. AZACITIDINE, Lisaftoclax, Dummy APG-2575 oral tablets, matching APG-2575 oral tablets. strength: 200 mg/tablet., AZACITIDINE

    Pharma

    Acute myeloid leukemia

    phase 3 small molecule active

    1 trial

  12. Abemaciclib, Lasofoxifene, Fulvestrant

    Pharma

    Locally advanced or metastatic breast cancer

    phase 3 small molecule active

    1 trial

  13. Amisulpride, DEXAMETHASONE PHOSPHATE, ONDANSETRON

    Pharma

    post-operative nausea and vomiting in pediatric patients

    phase 3 small molecule active

    1 trial

  14. An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria

    Pharma

    Primary Hyperoxaluria

    phase 3 other active

    1 trial

  15. Angoron 150 mg/3 ml amp ενέσιμο διάλυμα, FLECARDIA Διάλυμα για ένεση/έχχυση

    Pharma

    Cardioversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary artery disease without residual ischemia and an left ventricular ejection fraction > 35%

    phase 3 small molecule active

    1 trial

  16. Atenativ 1000 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Atenativ, 50 IU/ml, prášek a rozpouštědlo pro infuzní roztok, Atenativ 500 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Atenativ 50 i.e./ml prašek in vehikel za raztopino za infundiranje, Atenativ 50 IU/ml prášek a rozpouštědlo pro infuzní roztok, ATENATIV 50 UI/mL, poudre et solvant pour solution pour perfusion, ATENATIV 50 UI/mL, poudre et solvant pour solution p

    Pharma

    Acquired Antithrombin Deficiency (Heparin Resistance)

    phase 3 small molecule active

    1 trial

  17. Atumelnant 120 mg tablets, Atumelnant 80 mg tablets, Tablet

    Pharma

    Classic Congenital Adrenal Hyperplasia

    phase 3 small molecule active

    1 trial

  18. Atumelnant 80 mg tablets, Atumelnant 40 mg tablet, Atumelnant 20 mg tablets, Tablet

    Pharma

    Classic congenital adrenal hyperplasia

    phase 3 small molecule active

    1 trial

  19. Azacitidin Zentiva 25 mg/ml Pulver zur Herstellung einer Injektionssuspension, Azacitidine 25 mg/mL powder for suspension for injection, SY-1425, Placebo for Tamibarotene (SY-1425), AZACITIDINE

    Pharma

    Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  20. BRUKINSA 80 mg hard capsules, Calquence 100 mg film-coated tablets, IMBRUVICA 140 mg film-coated tablets, Lisaftoclax, IMBRUVICA 140 mg hard capsules, Lisaftoclax, Calquence 100 mg film-coated tablets, IMBRUVICA 140 mg film-coated tablets, Lisaftoclax, Calquence 100 mg hard capsules, IMBRUVICA 140 mg hard capsules, Calquence 100 mg hard capsules

    Pharma

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  21. Beltavac Polymerized placebo. It is a saline solution without the allergenic extract, BELTAVAC with polymerized extract From Dermatophagoides

    Pharma

    Allergic rhinoconjunctivitis due to exposure of house dust mites

    phase 3 small molecule active

    1 trial

  22. Berotralstat, Orladeyo 150 mg hard capsules, Berotralstat, Berotralstat, Berotralstat

    Pharma

    Hereditary Angioedema (HAE)

    phase 3 small molecule active

    1 trial

  23. Betahistine dihydrochloride, BETASERC 24 mg, comprimé

    Pharma

    Menière's disease

    phase 3 small molecule active

    1 trial

  24. Bexicaserin, LP352 (bexicaserin) Placebo Oral Solution

    Pharma

    Dravet Syndrome

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Pharma?

Pharma (E2629AD) is a pharma company. headquartered in Colmenar Viejo, ES. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Pharma sponsor?

We track 24 ClinicalTrials.gov-linked programs for Pharma, including -, PARACETAMOL , CILAZAPRIL , Dapirolizumab pegol, EPINEPHRINE , DIPHENHYDRAMINE , -, -, -, -, -, -, - and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Pharma company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.